The extent to which this pathway operates identically in additional breast cancer subtypes (or other cancers altogether) will necessitate the detailed determination of cellular SOCS5 targets, partners, and mechanism-of-action in a context-dependent fashion. This evidence concerns the gene SOCS5 and breast carcinoma.